Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]

Group 1 - Alight, Inc. reported Q4 2025 results that fell below the low end of its own guidance, with revenue declining 4% year over year [2] - The company had previously projected full-year 2025 EPS between $0.54 and $0.58 and revenue between $2.25 billion and $2.28 billion [2] - Leadership changes at the CEO and CFO level were disclosed in the earnings release, which had not been mentioned in prior earnings calls [3] Group 2 - The company announced that its quarterly dividend would be replaced, indicating potential shifts in financial strategy [3] - CEO David Guilmette had previously expressed confidence in the company's long-term position despite the recent performance issues [3] - Levi & Korsinsky has initiated an investigation into Alight, Inc. for potential violations of federal securities laws, indicating possible legal challenges ahead for the company [1]

Core Insights - IREN Limited is recognized for its early understanding that AI infrastructure will significantly drive power-dense data centers, leading to a bullish outlook on the stock since it traded around $14 [1] Group 1: Investment Strategy - Pythia Research focuses on identifying multi-bagger stocks, particularly in the technology sector, by combining financial analysis with behavioral finance and alternative metrics [1] - The investment approach aims to uncover breakout opportunities before they gain mainstream attention, leveraging both traditional and unconventional insights [1] - The strategy emphasizes understanding market sentiment and identifying emerging trends to invest in transformative businesses poised for exponential growth [1] Group 2: Market Behavior Analysis - The company acknowledges that markets are influenced not only by fundamentals but also by perception, emotion, and bias, which can create persistent inefficiencies [1] - Psychological factors such as herd mentality and recency bias can lead to mispricing, marking the beginning of breakout opportunities [1] - The analysis of investor behavior, including status quo bias and fear of uncertainty, is crucial for recognizing companies that are redefining their categories [1] Group 3: Research Methodology - The research process involves deep analysis and signals that others may overlook, such as shifts in narrative, early social traction, and underappreciated momentum in user adoption [1] - The focus is on conviction plays with a favorable risk/reward profile, aiming for limited downside and explosive upside potential [1] - The belief is that the best returns come from understanding where investor belief lags behind reality [1]

Core Insights - PROCEPT BioRobotics Corporation is under investigation for potential violations of federal securities laws, as announced by Levi & Korsinsky [1] Financial Performance - In the Q3 2025 earnings call, CFO Kevin Waters reaffirmed a revenue target of $325.5 million and maintained average selling prices for handpieces at approximately $3,200 [2] - The company implemented a pricing-discipline initiative that eliminated bulk-purchase discounts, which directly reduced realized average selling prices on its core product line [2] - Actual revenue for Q4 2025 fell short by $17.4 million compared to the guidance, and the FY 2026 revenue guidance of $410 million to $430 million was also below analyst consensus, leading to a 15% drop in stock value in a single session [3]

Core Viewpoint - Levi & Korsinsky has initiated an investigation into Gartner, Inc. regarding potential violations of federal securities laws, particularly focusing on the company's financial disclosures and the prominence of various financial metrics in their communications [1][3]. Financial Performance - Gartner's fourth quarter earnings release on February 3, 2026, highlighted an earnings-per-share (EPS) beat compared to analyst estimates, but also revealed that revenue fell short of consensus expectations and projected a year-over-year decline for the full year 2026 [3]. - The company had previously guided investors to expect an adjusted EPS of at least $12.65 for 2025, based on 78 million shares and anticipated stock repurchases to offset dilution [4]. Stock Market Reaction - Following the earnings release, Gartner's shares dropped over 20% during midday trading, reaching a new 52-week low below $160, with trading volume significantly exceeding normal levels [5].

Core Insights - Grocery Outlet Holding Corp. is under investigation for potential violations of federal securities laws, as announced by Levi & Korsinsky [1] - The company has revised its FY2025 comparable-store sales outlook to a range of 0.6%-0.9%, a decrease from the previous range of 0.6%-1.2% [2] - Plans to close 36 under-performing stores, representing approximately 6% of the total store base, were announced months later, which were not mentioned during the Q3 2025 earnings call [3] - The FY2026 guidance provided in the same earnings release was significantly below analyst expectations [3] Company Performance - Management expressed confidence in the outlook for gross margin, adjusted EBITDA, and adjusted EPS despite the lowered sales outlook [2] - The closure of stores and the subsequent guidance indicate potential challenges in maintaining growth and profitability [3]

Core Insights - Amphastar Pharmaceuticals, Inc. (AMPH) is identified as a small pharmaceutical company with a portfolio that includes both generic and proprietary drugs, which is considered undervalued [1] Investment Strategy - The investment approach combines fundamental analysis with options trading, focusing on various strategies such as income-oriented investments, growth at a reasonable price, deep value, and dividend aristocrats [1] - The company employs 20-25 different options strategies for purposes including hedging, bullish substitutes, neutral trades, trading volatility, and earnings-related trades [1] Teaching and Community Engagement - The company has a passion for teaching and has previously engaged in both formal and informal educational roles, including authoring a free local investing newsletter [1]

Core Viewpoint - ICON Public Limited Company is under investigation for potential violations of federal securities laws, following a significant decline in shareholder value due to a revenue overstatement and a delay in financial results [1][2]. Group 1: Financial Performance and Market Reaction - The recent single-day decline in ICON's stock wiped out billions of dollars in shareholder value, marking one of the largest percentage drops in the Contract Research Organization (CRO) sector in recent years [2]. - Prior to the disclosure, ICON's stock traded within a range that reflected investor confidence, with analyst consensus estimating full-year 2025 revenue between $8.05 billion and $8.1 billion, and adjusted EPS guidance of $13.00 to $13.20 [2]. - The company disclosed a preliminary revenue overstatement of under two percent per year for fiscal years 2023 and 2024, which led to the delay in releasing Q4 and full-year 2025 results [3]. Group 2: Management Statements and Stock Buybacks - CEO Barry Balfe had previously indicated that the company's performance was "broadly in line with expectations," while CFO Nigel Clerkin reported Q3 2025 revenue of $2.043 billion, reflecting a year-over-year increase of 0.6 percent [3]. - In the quarters leading up to the disclosure, ICON repurchased $750 million of its own stock and had a new $1 billion buyback authorization approved, indicating management's confidence in the company's financial position [4]. - A filing on January 7, 2026, stated that full-year 2026 guidance would be issued alongside the delayed Q4 and full-year 2025 results, which has now been rendered moot [4].

Core Insights - The situation in the Strait of Hormuz remains critical, with Iran acting as a gatekeeper for crude exports, particularly to Asia, despite ongoing tensions and sanctions [3][5][29] - China's reliance on Iranian crude exports is significant, and any resolution to sanctions could adversely affect China's energy security [5][9] - The International Energy Agency (IEA) is releasing stockpiles to mitigate supply shortages, but logistical challenges may delay the impact on the market [15][19][25] Group 1: Iran's Export Dynamics - Iran continues to export crude through the Strait of Hormuz, with over 90% of its exports originating from K Island, making rerouting difficult [2][3] - The JASP terminal outside the Strait of Hormuz has seen limited use, but there is potential for Iran to pipe crude for export from there [1][2] - The ongoing geopolitical tensions are causing fluctuations in tanker availability, impacting crude loading and exports [24][26] Group 2: Impact on China - China consumes approximately 15 million barrels of oil per day, with the Middle East supplying about 5 million barrels daily, making it vulnerable to supply disruptions [8][9] - The sanctions on Iranian and Venezuelan crude have led to a significant reduction in supply to China, which could force adjustments in refinery operations [5][6][9] - Despite having substantial oil reserves, China's consumption rates mean that any supply cut will necessitate a drawdown of inventories [7][9] Group 3: Market Reactions and Supply Gaps - The market is currently facing a supply gap estimated between 15 to 25 million barrels per day, with the IEA's stockpile release expected to cover only a fraction of this [21][22] - The logistical limitations of stockpile releases mean that the market may not feel the effects immediately, leading to potential future shortages [19][25] - The situation is exacerbated by geopolitical tensions, with the U.S. military presence potentially escalating conflicts in the region [26][29]

Group 1 - Gossamer Bio, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws [1] - The company's lead pipeline candidate, Seralutinib, was evaluated in the PROSERA study, a pivotal Phase 3 trial for pulmonary arterial hypertension [2] - During the Q1 2025 earnings call, the CEO expressed optimism about the trial's results, stating that the baseline characteristics were targeted and that there was "over 90% power given the sample size," although the primary efficacy endpoint did not achieve statistical significance [3] Group 2 - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders and being recognized as one of the top securities litigation firms in the U.S. for seven consecutive years [5]